Helena Laboratories, Corp. recalls ColoCARE, Cat. No. 5651, packaged 50 envelopes/box, For In-Vitro Diagnostic Use. The firm name on the label is Helena L…
- Recall date
- August 8, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1950-2019
- FDA classification
- Class II
- Brand / firm
- Helena Laboratories, Corp.
- Sold / distributed
- Distribution was made to AK, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, MS, MT, NC, ND, NE, NV, NY, OH, OK, PA, SD, TN, TX, VA, WA, and WY. There was no foreign/military/government distribution.
Why it was recalled
The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning correctly.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ColoCARE, Cat. No. 5651, packaged 50 envelopes/box, For In-Vitro Diagnostic Use. The firm name on the label is Helena Laboratories, Beaumont, TX.
Get recall alerts
Free email alert whenever Helena Laboratories, Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Helena Laboratories, Corp.